B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • RnM3784338
  • |
  • 26 September, 2019
  • |
  • 147 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

Request a Sample Report



Purchase this Report

$10,995.00
$21,990.00
$32,985.00
8,752.02
17,504.04
26,256.06
10,214.36
20,428.71
30,643.07
1,692,570.30
3,385,140.60
5,077,710.90
918,192.45
1,836,384.90
2,754,577.35
Credit card Logo